Trial intelligence / Profile preview

Tinzaparin vs Oral Anticoagulation for Long-Term DVT Treatment

NCT00689520Phase 4Completed

Sponsor
Bellvitge University Hospital
Start
Jan 2002
Primary completion
Jan 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of tinzaparin in deep vein thrombosis (DVT), sponsored by Bellvitge University Hospital. Started Jan 2002; status: completed.

02

Drugs

tinzaparin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT00689520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00689520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call